LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Platform X-BODY Biosciences utilizes a cutting-edge DNA-tagged human antibody library to discover novel therapeutic targets, presenting opportunities for collaborations in advanced antibody development.

Early-stage Focus With revenue under one million and recent funding of 2.7 million dollars, the company is in an early growth phase, making it potentially receptive to strategic investments, partnerships, or pilot projects.

Niche Therapeutics Focusing on novel biotherapeutic compounds, X-BODY operates in a highly specialized segment, offering avenues to support research tools, assay development, or custom antibody solutions for targeted therapies.

Partnership Opportunities Given its small size and innovative approach, X-BODY may be interested in building collaborations with larger biotech firms or research institutions to accelerate drug discovery programs.

Market Potential Operating in a competitive landscape with similar small to mid-sized companies, X-BODY offers prospects for tailored solutions, licensing deals, or joint ventures to expand its product pipeline.

X-BODY Biosciences Tech Stack

Media & News

X-BODY Biosciences's Email Address Formats

X-BODY Biosciences uses at least 1 format(s):
X-BODY Biosciences Email FormatsExamplePercentage
First.Last@x-bodybiosciences.comJohn.Doe@x-bodybiosciences.com
50%
FLast@x-bodybiosciences.comJDoe@x-bodybiosciences.com
50%

Frequently Asked Questions

Where is X-BODY Biosciences's headquarters located?

Minus sign iconPlus sign iconX-BODY Biosciences's main headquarters is located at 100 Beaver Street Suite 101 Waltham, Massachusetts 02453 United States. The company has employees across 2 continents, including North AmericaAsia.

What is X-BODY Biosciences's official website and social media links?

Minus sign iconPlus sign iconX-BODY Biosciences's official website is x-bodybiosciences.com and has social profiles on LinkedInCrunchbase.

What is X-BODY Biosciences's SIC code NAICS code?

Minus sign iconPlus sign iconX-BODY Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does X-BODY Biosciences have currently?

Minus sign iconPlus sign iconAs of February 2026, X-BODY Biosciences has approximately 3 employees across 2 continents, including North AmericaAsia. Key team members include Private Equity Analyst: L. M.: J. G.. Explore X-BODY Biosciences's employee directory with LeadIQ.

What industry does X-BODY Biosciences belong to?

Minus sign iconPlus sign iconX-BODY Biosciences operates in the Biotechnology Research industry.

What is X-BODY Biosciences's email format?

Minus sign iconPlus sign iconX-BODY Biosciences's email format typically follows the pattern of First.Last@x-bodybiosciences.com. Find more X-BODY Biosciences email formats with LeadIQ.

How much funding has X-BODY Biosciences raised to date?

Minus sign iconPlus sign icon As of February 2026, X-BODY Biosciences has raised $2.7M in funding. The last funding round occurred on Feb 12, 2013 for $2.7M.

X-BODY Biosciences

Biotechnology ResearchMassachusetts, United States2-10 Employees

X-BODY Biosciences is a privately held biotechnology company focused on identifying novel biotherapeutic compounds. It aims to generate human antibodies against novel therapeutic targets by leveraging a diverse library of DNA-tagged human antibodies, and it is based in Waltham, Massachusetts.

Operating in the biotechnology research sector, the company centers its activities on discovery within the field. With a small team, it seeks to support researchers and developers pursuing new antibody-based therapies for previously unaddressed targets.

Section iconCompany Overview

Headquarters
100 Beaver Street Suite 101 Waltham, Massachusetts 02453 United States
Website
x-bodybiosciences.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $2.7M

    X-BODY Biosciences has raised a total of $2.7M of funding over 2 rounds. Their latest funding round was raised on Feb 12, 2013 in the amount of $2.7M.

  • $1M

    X-BODY Biosciences's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $2.7M

    X-BODY Biosciences has raised a total of $2.7M of funding over 2 rounds. Their latest funding round was raised on Feb 12, 2013 in the amount of $2.7M.

  • $1M

    X-BODY Biosciences's revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    L. M.
    Private Equity Analyst
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. G.
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.